195 related articles for article (PubMed ID: 9305314)
1. Prostate cancer metastatic only to the penis.
Celebi MM; Venable DD; Nopajaroonsri C; Eastham JA
South Med J; 1997 Sep; 90(9):959-61. PubMed ID: 9305314
[TBL] [Abstract][Full Text] [Related]
2. [Loss of differentiation of a prostate adenocarcinoma after hormone therapy: the example of a metastasis in the spongy body of the penis].
Uphoff J; Woziwodzki J; Schattka SO; Kollias A
Aktuelle Urol; 2008 Sep; 39(5):373-7. PubMed ID: 18798127
[TBL] [Abstract][Full Text] [Related]
3. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
[TBL] [Abstract][Full Text] [Related]
4. Case records of the Massachusetts General Hospital. Case 16-2011. A 67-year-old man with recurrent prostate cancer.
Smith MR; Zietman AL; Finkelstein JS; Wu CL
N Engl J Med; 2011 May; 364(21):2044-51. PubMed ID: 21612474
[No Abstract] [Full Text] [Related]
5. Penile metastasis from a T1b prostate carcinoma.
Cai T; Salvadori A; Nesi G; Detti B; Tinacci G; Zini E; Bartoletti R
Onkologie; 2007 May; 30(5):249-52. PubMed ID: 17460419
[TBL] [Abstract][Full Text] [Related]
6. Penile metastasis of prostatic adenocarcinoma.
Senkul T; Karademir K; Silit E; Işeri C; Erden D; Baloğlu H
Int J Urol; 2002 Oct; 9(10):597-8. PubMed ID: 12445240
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical monitoring of micrometastatic disease: reduction of prostate cancer cells in bone marrow by androgen deprivation.
Pantel K; Enzmann T; Köllermann J; Caprano J; Riethmüller G; Köllermann MW
Int J Cancer; 1997 May; 71(4):521-5. PubMed ID: 9178803
[TBL] [Abstract][Full Text] [Related]
8. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
[TBL] [Abstract][Full Text] [Related]
9. Priapism as the initial manifestation of a penile and lower limb cutaneous metastasis of prostate adenocarcinoma with low serum PSA level.
He D; Zeng J; Li X; Wu K; Wu D; He H; Song W; Li L
J Androl; 2012; 33(6):1160-4. PubMed ID: 22700763
[TBL] [Abstract][Full Text] [Related]
10. Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Efstathiou E; Bozas G; Kostakopoulos A; Kastritis E; Deliveliotis C; Antoniou N; Skarlos D; Papadimitriou C; Dimopoulos MA; Bamias A
Urology; 2005 Jan; 65(1):126-30. PubMed ID: 15667877
[TBL] [Abstract][Full Text] [Related]
11. Penile metastasis from adenocarcinoma of the prostate in a patient with colorectal carcinoma.
Yildiz B; Fidan E; Yildiz K; Aydin F
Acta Dermatovenerol Croat; 2011; 19(1):36-8. PubMed ID: 21489365
[TBL] [Abstract][Full Text] [Related]
12. Penile metastasis of prostatic adenocarcinoma. Case report.
Sánchez LO; Rodríguez IG; Prieto MA; Zamora IC; Arteaga SM; Franco EH; Rolania FJ
Arch Esp Urol; 2011 Dec; 64(10):985-7. PubMed ID: 22228897
[TBL] [Abstract][Full Text] [Related]
13. [Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy].
Barbón JJ; González-Tuero J; Gay LL; Pérez-García FJ; Sampedro A
Arch Soc Esp Oftalmol; 2007 Nov; 82(11):715-7. PubMed ID: 17979041
[TBL] [Abstract][Full Text] [Related]
14. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
[TBL] [Abstract][Full Text] [Related]
15. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.
Wieder JA; Soloway MS
J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867
[TBL] [Abstract][Full Text] [Related]
16. Proptosis of eye: an atypical presentation of prostatic malignancy.
Amjad A; Osmani AH; Haider G
J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S39-40. PubMed ID: 25933459
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy.
Ravi P; Karnes RJ; Rangel LJ; Pagliaro LC
J Urol; 2018 Nov; 200(5):1075-1081. PubMed ID: 29709664
[TBL] [Abstract][Full Text] [Related]
18. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.
Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A
Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439
[TBL] [Abstract][Full Text] [Related]
19. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S
Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of prostate metastatic to penis.
Mugharbil ZH; Childs C; Tannenbaum M; Schapira H
Urology; 1985 Mar; 25(3):314-5. PubMed ID: 2579501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
